Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Supportive Care in Cancer
Literature
1.
Argyriou AA, Zolota V, Kyriakopoulou O, Kalofonos HP (2010) Toxic peripheral neuropathy associated with commonly used chemotherapeutic agents. J BUON 15(3):435–446PubMed
2.
Kottschade LA, Sloan JA, Mazurczak MA, et al (2010) The use of vitamin E for the prevention of chemotherapy-induced peripheral neuropathy: results of a randomized phase III clinical trial. Support Care Cancer. doi:10.​1007/​s00520-010-1018-3
3.
Pace A, Giannarelli D, Galiè E et al (2010) Vitamin E neuroprotection for cisplatin neuropathy: a randomized, placebo-controlled trial. Neurology 74(9):762–766PubMedCrossRef
4.
Argyriou AA, Chroni E, Koutras A et al (2006) A randomized controlled trial evaluating the efficacy and safety of vitamin E supplementation for protection against cisplatin-induced peripheral neuropathy: final results. Support Care Cancer 14(11):1134–1140PubMedCrossRef
5.
Argyriou AA, Chroni E, Koutras A et al (2006) Preventing paclitaxel-induced peripheral neuropathy: a phase II trial of vitamin E supplementation. J Pain Symptom Manage 32(3):237–244PubMedCrossRef
6.
Cavaletti G, Frigeni B, Lanzani F et al (2010) Chemotherapy-induced peripheral neurotoxicity assessment: a critical revision of the currently available tools. Eur J Cancer 46(3):479–494PubMedCrossRef
7.
Cavaletti G, Frigeni B, Lanzani F, Italian NETox Group et al (2007) The Total Neuropathy Score as an assessment tool for grading the course of chemotherapy-induced peripheral neurotoxicity: comparison with the National Cancer Institute-Common Toxicity Scale. J Peripher Nerv Syst 12(3):210–215PubMedCrossRef
Metadata
Title
Vitamin E for preventing chemotherapy-induced peripheral neuropathy
Authors
Andreas A. Argyriou
Haralabos P. Kalofonos
Publication date
01-05-2011
Publisher
Springer-Verlag
Published in
Supportive Care in Cancer / Issue 5/2011
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-011-1090-3

Other articles of this Issue 5/2011

Supportive Care in Cancer 5/2011 Go to the issue

Original Article

Physical activity, quality of life, and the interest in physical exercise programs in patients undergoing palliative chemotherapy

Short Communication

Development and pilot testing of a communication aid to assist clinicians to communicate with women diagnosed with ductal carcinoma in situ (DCIS)

Letter to the Editor

Response to letter to the editor referencing manuscript the “Use of vitamin E for the prevention of chemotherapy-induced peripheral neuropathy: results of a randomized phase III clinical trial”

Original Article

Healing action of topical chamomile on 5-fluouracil induced oral mucositis in hamster

Short Communication

Effect of massage therapy on stress levels and quality of life in brain tumor patients—observations from a pilot study

Original Article

Psychometric properties of the Perform Questionnaire: a brief scale for assessing patient perceptions of fatigue in cancer
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits